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Parainfluenza viruses are important causes of respi-
ratory disease in both children and adults. In particular,
they are the major cause of the serious childhood illness
croup (laryngotracheobronchitis). The infections pro-
duced by parainfluenza viruses are associated with the
accumulation of ions and fluid in the respiratory tract.
It is not known, however, whether this accumulation is
because of a direct effect of the viruses on ion and fluid
transport by the respiratory epithelium. Here we show
that a model parainfluenza virus (the Sendai virus), in
concentrations observed during respiratory infections,
activates Cl secretion and inhibits Na absorption
across the tracheal epithelium. It does so by binding to a
neuraminidase-insensitive glycolipid, possibly asialo-
GM1, triggering the release of ATP, which then acts in
an autocrine fashion on apical P2Y receptors to produce
the observed changes in ion transport. These findings
indicate that fluid accumulation in the respiratory tract
associated with parainfluenza virus infection is attrib-
utable, at least in part, to direct effects of the virus on
ion transport by the respiratory epithelium.
The volume of fluid in the respiratory tract is determined by
the balance between the rate of fluid secretion and the rate of
fluid absorption by the respiratory epithelium. The secretion of
fluid is due to the movement of Cl into the lumen through
cystic fibrosis transmembrane conductance regulator protein
Cl channels and Ca2-activated Cl channels in the apical
membranes of the epithelial cells and is driven by the Na-K-
2Cl cotransporter in their basolateral membranes (1). The
absorption of fluid is because of the movement of Na across
the apical membrane through epithelial Na channels (1–3).
The Na is then pumped out of the cytosol across the basolat-
eral membrane by the Na,K-ATPase.
Given the importance of ion transport across the respiratory
epithelium in determining the volume of the lung surface fluid,
it is not surprising that disturbances in it lead to pathological
changes in the volume of lung fluid. Hence excessive activity of
epithelial Na channels, such as occurs in cystic fibrosis (4),
leads to dehydration of the respiratory surfaces, whereas re-
duced activity of epithelial Na channels, such as occurs in
pseudohypoaldosteronism type I, is associated with an increase
in lung surface fluid (3). Similarly, reduced activity of the
epithelial Na channels in the respiratory epithelium has been
implicated in the development of high altitude pulmonary
edema (5), neonatal respiratory distress syndrome (6), cardio-
genic pulmonary edema (7), and serous otitis media (8).
Parainfluenza viruses are a major cause of respiratory dis-
ease (9), producing laryngotracheobronchitis (croup) in chil-
dren (10) as well as bronchiolitis and pneumonia in children
(11, 12) and in adults (13). They are disseminated by large
droplet spread and are highly contagious, over 75% of children
are infected by parainfluenza viruses at least once during their
first 5 years of life (9). The infections caused by them are
associated with fluid accumulation in the respiratory tract,
which ranges in severity from rhinitis (9) and serous otitis
media (14) to a life-threatening adult respiratory disease syn-
drome (15). The question thus arises whether parainfluenza
viruses could be directly affecting ion transport by the respira-
tory epithelium. One common respiratory virus, the influenza
virus, has been shown to directly inhibit Na absorption by the
respiratory epithelium (16). This inhibition is because of the
binding of the hemagglutinin in the viral coat to a neuramini-
dase-sensitive receptor in the apical membrane of the epithe-
lium and is mediated by activation of phospholipase C and
protein kinase C (16). Despite the similarity of their names,
which reflects the similarity of the clinical features they pro-
duce, influenza viruses and parainfluenza viruses are unre-
lated (9). Influenza viruses have a segmented genome and
replicate in the nucleus, whereas the parainfluenza viruses
have a non-segmented genome and replicate in the cytoplasm
(9). Thus it is not possible to assume that parainfluenza viruses
affect epithelial ion transport in the same way as influenza
viruses.
In the present study we performed experiments to determine
whether parainfluenza viruses rapidly alter ion transport by
respiratory epithelia. We found that not only do they inhibit
the absorption of the Na by these epithelia, they also activate
epithelial secretion of Cl. Furthermore, we found that the
mechanism by which parainfluenza viruses alter epithelial ion
transport differs markedly from that used by influenza viruses.
EXPERIMENTAL PROCEDURES
Viruses—Sendai virus, the gift of Dr. A. Mu¨hlbacher (John Curtin
School of Medical Research, Canberra ACT), was grown for 2 days in the
allantoic cavity of 10-day old embryonated eggs from hens. Aliquots of
allantoic fluid containing the virus were stored at 80 °C. The viral stock
solution was titered on monolayers of Madin-Darby canine kidney cells
(17).
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Cell Culture—M-1 mouse cortical-collecting duct cells, provided by
Dr. C. Korbmacher (University of Erlangen, Germany), were grown to
confluence for 3 days on permeable supports (Transwell-Coll, Costar,
Cambridge, MA) in Dulbecco’s modified Eagle’s medium/F12 medium
containing 10% fetal calf serum, glutamine (2 mM), penicillin (100,000
units/liter), streptomycin (100,000 units/liter) and dexamethasone
(0.1 M).
Ussing Chamber Experiments—Quackenbush-Swiss mice were killed
by cervical dislocation. The trachea were then removed, freed of con-
nective tissue, opened longitudinally, and divided into small pieces that
were stored in a chilled solution containing 145 mM NaCl, 3.8 mM KCl,
5 mM D-glucose, 1 mM MgCl2, 5 mM HEPES, 1.3 mM calcium gluconate,
pH 7.4. Each tracheal piece was mounted in an Ussing chamber (18)
having a circular aperture of 0.95 mm2. The apical and basolateral
surfaces of the epithelium were perfused continuously with aerated
solutions at a rate of 10–20 ml/min (chamber volume 1 ml) at 37 °C. The
bath solution contained 145 mM NaCl, 0.4 mM KH2PO4, 1.6 mM
K2HPO4, 5 mM D-glucose, 1 mM MgCl2, 1.3 mM calcium gluconate, pH
7.4. All experiments were carried out under open circuit conditions. The
transepithelial potential difference (Vte) was recorded relative to the
serosal side, and current was defined as positive when conventional
current flowed in the apical to serosal direction. The transepithelial
resistance (Rte) was determined, and the equivalent short circuit cur-
rent was calculated as described previously (16).
Compounds—3-Isobutyl-1-methylxanthine, forskolin, amiloride, bu-
metanide, UTP, pertussis toxin holoenzyme, pertussis toxin B oligomer,
carbachol, BAPTA-AM,1 bisindolylmaleimide I (BIM), hexokinase, and
suramin were all obtained from Sigma. The phospholipase C inhibitors,
U-73122 and edelfosine, the inactive analogue of U-73122, U-73343,
the MAP kinase inhibitors, SB-203580 and U-0126, and the purinergic
receptor antagonist, pyridoxalphosphate-6-azophenyl-2,4-disulfonic
acid (PPADS) were all from Calbiochem. 1-Phenyl-2-hexadecanoy-
lamino-3-morpholino-1-propanol (PPMP) was from Adelab Scientific
(Norwood, SA). Neuraminidase was from Roche Applied Science. The
anti-ASGM1 antibody was from Wako (Japan).
Statistics—Results are presented as the means  S.E. (n  number
of tissues tested). Statistical significance was assessed using unpaired
Student’s t tests at a probability level of p  0.05. Asterisks in figures
indicate statistically significant differences from control.
RESULTS
The Baseline Electrical Properties of Mouse Tracheal Epithe-
lium—The rate at which the tracheal epithelium secretes Cl
ions and absorbs Na ions can be measured by determining the
current flow generated by the movement of these ions across
the epithelium. We can do this by measuring the electrical
potential difference across the epithelium (the transepithelial
potential, Vte) and the change in the transepithelial potential
produced by the passage of a standard test pulse of current. We
can then use Ohm’s Law to estimate the resistance of the
epithelium to the flow of the test pulse of current (the transepi-
thelial resistance, Rte), as well as the current that is required to
generate the observed transepithelial potential (the so-called
short circuit current, Isc  Vte/Rte).
To make these measurements, we placed a small piece of
trachea in an Ussing chamber, an organ bath that permits the
luminal and interstitial surfaces of the tissue to be superfused
by separate solutions and the continuous measurement of tran-
sepithelial potential and resistance. Under control conditions,
we found the potential difference across the tracheal epithe-
lium to be 7.3  0.6 mV (n  23), with the lumen being
negative to the interstitium and the electrical resistance of the
epithelium to be 79.4  5.2  cm2 (n  23). From these meas-
urements we calculated the short circuit current across the
epithelium to be 98.3 7.8 A cm2 (n 23). This current flow
was largely because of the transport of Na through amiloride-
sensitive Na channels, as the application of amiloride (10 M),
a selective inhibitor of these channels, to the apical surface of
the epithelium reduced the short circuit current by 90.2  6.9
A cm2 (n  23), a 92% reduction.
The Effects of Sendai Virus—Exposure of the apical mem-
brane of mouse tracheal epithelium to the Sendai virus (106
pfu/ml) caused the transepithelial potential and the short
circuit current to become transiently more negative (Fig. 1A,
Vte  1.2  0.2 mV, n  8; Isc  43.1  9.0 A cm
2).
This transient occurred within 	1 min of adding the virus to
the epithelium and lasted 	5 min. It could have been due
either to an increase in the rate of Cl secretion or to an
increase in the rate of Na absorption. We found that it could
not be prevented by inhibiting Na absorption by the addition
of 10 M amiloride to the apical membrane (data not shown),
and hence could not be attributed to an increase in the rate of
Na absorption. It could be inhibited, however, by blocking the
secretion of Cl by the addition to the basolateral membrane of
100 M bumetanide, an inhibitor of the Na-K-2Cl cotrans-
porter (data not shown). Hence the initial transient stimulation
of the short circuit current was because of an increase in the
rate of Cl secretion. We further found that this transient
stimulation of short circuit current required an increase in the
intracellular concentration of Ca2, as it could be prevented by
maneuvers that clamp cytosolic Ca2 at a low level, such as the
removal of extracellular Ca2 or loading the cytosol with the
Ca2 chelator, BAPTA (see Fig. 4). Hence the initial increase in
short circuit current produced by Sendai virus was because of
the activation of Ca2-activated Cl channels in the apical
membrane of the epithelium.
After the epithelium had been exposed to the virus for 1 h
(Fig. 1A), the transepithelial potential had fallen from 5.6 
0.6 mV (n 8) to3.3 0.2 mV (n 8), and the transepithelial
resistance had increased from 49.7  5.0  cm2 (n  8) to
67.5  8.4  cm2 (n  8). From these measurements we calcu-
lated that the short circuit current across the epithelium had
declined from117.7 17.1 A cm2 (n 8) to52.7 6.6 A
cm2 (n  8). This decrease in current flow during prolonged
exposure to parainfluenza virus was almost entirely because of
a reduction in the rate of amiloride-sensitive Na transport
(Fig. 1B). In paired control experiments, the ion transport
activity of the epithelium did not change over this period (Fig.
1B). The addition of allantoic fluid also did not affect the ion
transport activity of the epithelium (data not shown). We fur-
ther found that, as we had previously observed for influenza
virus (16), the action of the Sendai virus on the epithelium was
not prevented by an UV inactivation of the virus. A UV light-
inactivated virus produced an initial transient increase in the
short circuit current of 23.4  6.0 A cm2 (n  5) and, after
1 h of exposure, reduced the rate of amiloride-sensitive Na
absorption from89.4 9.3 A cm2 (n 5) to50.1 4.2 A
cm2 (n  5).
To check whether the Sendai virus exerted a nonspecific
toxic effect, we examined the other parameters of the function
of the tracheal epithelium. In particular, we examined the
effect of the virus on (i) the rate of Cl secretion by the epithe-
lium in response to an increase in intracellular cyclic AMP
produced by exposure to the activator of the adenylate cyclase
forskolin (18), (ii) the rate of Cl secretion in response to an
increase in intracellular Ca2 produced by the muscarinic ag-
onist carbachol (18, 19), and (iii) the rate of electrogenic co-
transport of Na and glucose across the epithelium (16, 20). We
found (Fig. 1C) that although exposure to the Sendai virus (106
pfu/ml) for 1 h reduced the response to 100 M forskolin, it did
not affect the response to 100 M carbachol or the rate of
electrogenic glucose transport. The virus thus appears not to
1 The abbreviations used are: BAPTA-AM, 1,2-bis(2-aminophe-
noxy)ethane-N,N,N,N-tetraacetic acid tetrakis(acetoxymethyl ester); BIM,
bisindolylmaleimide I; MAP, mitogen-activated protein; PPADS, pyridoxal-
phosphate-6-azophenyl-2,4-disulfonic acid; PPMP, 1-phenyl-2-hexade-
canoylamino-3-morpholino-1-propanol; pfu, plaque-forming unit; , ohm;
GM1, Gal1–3GalNAc1–4(Neu5Aca2-3)Gal1–4Glc1-1Cer.
Effects of Sendai Virus on Ion Transport 48761
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
have exerted a nonspecific toxic effect.
Finally, we examined the dependence of the ion transport
effects of the Sendai virus on the concentration of virus bathing
the apical membrane. We found that both the initial transient
stimulation of the short circuit current (Fig. 1D) and the longer
term inhibition of the amiloride-sensitive Na absorption (Fig.
1E) were dependent on the viral concentration over the range
104–106 pfu/ml. By comparison, the levels of the Sendai virus in
the lungs of infected mice reach 7 
 106 pfu/g of wet weight of
lung tissue or higher (21–23).
The Apical Membrane Target for Sendai Virus—We have
previously reported that the effects of the influenza virus on ion
transport in the mouse trachea can be inhibited by the treat-
ment of the apical membrane with neuraminidase (16). In the
present study, however, we found that pre-incubation with
neuraminidase (0.1 and 1 units/ml) for 30 min had no impact on
the actions of the Sendai virus (data not shown). Because
glycolipids have been reported to act as membrane receptors for
Paramyxoviruses, including Sendai (24), we also examined the
possibility that the effects of Sendai virus might be mediated by
a glycolipid. We first examined the effect of blocking glycolipid
synthesis using PPMP, an inhibitor of the enzyme glucosylce-
ramide synthase that requires 24 h or more to be effective (25).
Because we found that the incubation of the excised tracheal
epithelium for 24 h led to an irreversible deterioration of its
ion-transporting function, we performed these studies using
monolayers of the M1 mouse collecting duct cell line, a cell line
that, like the tracheal epithelium, absorbs Na through amilo-
ride-sensitive Na channels (26, 27). Furthermore, M1 cells
respond to Sendai virus in a similar manner to tracheal epi-
thelium, showing an initial transient stimulation in short cir-
cuit current followed by a longer term inhibition in the amilo-
ride-sensitive current (Fig. 2, E and F). We found that pre-
incubation of M1 mouse collecting duct cells in PPMP (20–40
M) for 24 h almost completely inhibited both the initial tran-
sient stimulation of short circuit current (Fig. 2F) and the
reduction of the amiloride-sensitive current (Fig. 2E) that fol-
lows the addition of 106 pfu/ml Sendai to the apical bathing
solution. In contrast, the inhibition of the amiloride-sensitive
current produced by the influenza virus in M1 cells was not
affected by pre-incubation in PPMP (data not shown).
We further explored the role of glycolipids in mediating the
effects of the Sendai virus by testing the effect of an antibody
directed against the ganglioside asialoGM1. This ganglioside
has been previously identified as the apical receptor by which
many bacterial pathogens evoke mucus and cytokine produc-
tion by epithelia (28, 29). We found that pre-incubation for 20
min in an anti-asialoGM1 antibody in a dilution of 1 in 100
completely inhibited the effects of the Sendai virus (Fig. 2, A, B,
and D). Interestingly, as reported in other systems (28, 29),
when added to tracheal epithelium at the lower dilution of 1 in
20, the antibody acted as an agonist, evoking a transient stim-
ulation of short circuit current followed by a long term depres-
sion of the amiloride-sensitive Na absorption (Fig. 2C).
Sendai Virus Acts by Triggering ATP Release—We next in-
vestigated whether the Sendai virus acted by triggering the
release of ATP, as has been reported following the exposure of
human respiratory cells to Pseudomonas aeruginosa (28). We
found that enzymatic destruction of ATP secreted from the
epithelium by the inclusion in the apical solution of hexokinase
plus glucose (30) completely inhibited the effects of the Sendai
virus (Fig. 3, A–C). Furthermore, the effects of the virus were
inhibited by the purinergic receptor antagonists, suramin, and
PPADS (Fig. 3, C–E).
Given that binding of asialoGM1 had been reported to in-
crease intracellular Ca2 (28, 29), we investigated whether the
actions of the Sendai virus are mediated by changes in intra-
cellular Ca2. We did this by incubating the epithelium in a low
Ca2 (1 M) solution buffered with 1 mM EGTA (Fig. 4, A and B)
or by pre-incubating the epithelium with the membrane-per-
FIG. 1. Effects of Sendai virus on
ion transport by mouse trachea. A,
original recording of the transepithelial
voltages (Vte) and the effects of amiloride
(A; 10 M) prior to and following a 1-h
incubation with the Sendai virus (106 pfu/
ml) or with control buffer. The initial
transient increase in transepithelial po-
tential that follows the addition of the
virus is marked by a dagger. The tran-
sepithelial potential (Vte) in the absence
of the test current pulse is marked with
an arrow. B, effects of a 1-h incubation in
Sendai virus or control buffer on amilo-
ride-sensitive short circuit currents (Isc-
Amil). C, effects of a 1-h incubation in Sen-
dai virus on the short circuit current
responses (Isc) induced by carbachol
(CCH, 100 M), by a mixture of isobutyl-
methylxanthine (100 M) and forskolin (2
M) (cAMP), or by luminal glucose (5 mM).
D, concentration-response relation for the
initial transient increase in short circuit
current (Initial Isc ) produced by the Sen-
dai virus. Initial Isc was measured as the
difference between the peak Isc observed
following the addition of Sendai and the
Isc observed immediately prior to its addi-
tion. E, concentration-response relation
for the inhibition of Isc-Amil produced by
incubation in Sendai virus for 1 h. Statis-
tically significant effects are marked with
an asterisk.
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meant Ca2 chelator BAPTA-AM (10 M) for 30 min (Fig. 4, C
and D). We found that both treatments inhibited the initial
transient stimulation of short circuit current produced by the
Sendai virus (Fig. 4, B and D) but did not affect the longer
term inhibition of amiloride-sensitive Na absorption (Fig. 4, A
and C).
The findings that the effects of the Sendai virus are mediated
by ATP acting on purinergic receptors and that they are medi-
ated in part by increasing intracellular Ca2 suggested roles
also for phospholipase C and protein kinase C. Consistent
with this we found that U-73122 (10 M; Fig. 5, D and F) and
edelfosine (10 M; data not shown), which are blockers of phos-
pholipase C, inhibited the effects of the virus, whereas the
inactive isomer of U-73122, U-73343 (20 M), was without
effect (data not shown). We also found that an inhibitor of
protein kinase C, BIM I (100 nM), partially inhibited the tran-
sient response to the Sendai virus (Fig. 5F), although it did not
prevent the inhibition of amiloride-sensitive Na absorption
(Fig. 5E).
The increased intracellular Ca2 concentration that accom-
panies binding of asialoGM1 has been reported to activate p38
and p42/44 MAP kinases (29, 31). We found, however, that
neither inhibition of p38 MAP kinase with 25 M SB-203580
nor inhibition of p42/44 MAP kinase with 25 M U-0126 inter-
fered with the actions of Sendai virus on ion transport (Fig. 5,
A, B, and F).
Finally, we examined whether a pertussis toxin-sensitive G
protein mediates the effects of the Sendai virus. We performed
these studies in the presence of BIM I, an inhibitor of protein
kinase C, because we have previously found that the B-oli-
gomer of the toxin, which is enzymatically inactive, acts as a
hemagglutinin and inhibits amiloride-sensitive Na absorp-
tion in mouse tracheal epithelium as a result of activating
protein kinase C (32). When we added Sendai virus to the
tracheal epithelium that had been pre-treated with pertussis
toxin in the presence of BIM I (100 nM), we found that the
magnitude of the transient stimulation of short circuit current
was not different from that observed in the presence of BIM I
alone (Fig. 5F). This treatment, however, abolished completely
the effects of the Sendai virus on the amiloride-sensitive Na
absorption (Fig. 5C). Exposure of the epithelium to the isolated
B-oligomer of the toxin in the presence of BIM I was without
effect (data not shown). Thus the action of Sendai virus on the
amiloride-sensitive Na absorption would appear to be medi-
ated by a pertussis toxin-sensitive G protein.
The Actions of UTP on the Tracheal Epithelium Have a
Similar Pharmacology to Those of Sendai Virus—As reported
FIG. 2. Investigation of the membrane target for the Sendai
virus. A, original recording of the transepithelial voltages (Vte) in
mouse trachea and effects of amiloride (Amil; 10 M) prior to and
following a 1-h incubation with the Sendai virus (106 pfu/ml) in the
absence or presence of an ASGM1 antibody (Anti-ASGM1; 1:100 dilu-
tion). B, effects on the amiloride-sensitive short circuit current (Isc-Amil)
of a 1-h incubation in Sendai virus (106 pfu/ml) in the absence or
presence of anti-ASGM1 antibody (1:100). C, effect of 1:100 and 1:20
dilutions of anti-ASGM1 antibody on Isc-Amil measured 10–15 min after
adding the antibody. D, impact on the initial transient increase in short
circuit current (Initial Isc) produced by the Sendai virus (10
6 pfu/ml) of
exposure to a 1:100 dilution of Anti-ASGM1 antibody. Panel E. The
impact of a 24-h incubation of M1 cells with PPMP (20 M) or with
control solution on the effect on Isc-Amil of a 1-h exposure to Sendai virus
(106 pfu/ml). F, the impact of a 24-h incubation of M1 cells with PPMP
(20 M) or with control solution on initial Isc produced by Sendai virus
(106 pfu/ml). Initial Isc was measured as the difference between the
peak Isc observed following the addition of Sendai and the Isc observed
immediately prior to its addition. Statistically significant effects are
marked with an asterisk.
FIG. 3. The actions of the Sendai virus are mediated by release
of ATP. A, original recording of the transepithelial voltage (Vte) in
mouse trachea and of the effects of amiloride (Am; 10 M) prior to and
following incubation for 1 h with Sendai virus (106 pfu/ml) in the
presence of hexokinase (5 units/ml) plus glucose (15 mM). B–E, effect on
the initial transient stimulation of short circuit current (Initial Isc)
and on the inhibition of the amiloride-sensitive short circuit current
(Isc-Amil) produced by the Sendai virus under control conditions or in the
presence of hexokinase plus glucose (B and C), suramin (B and D, 100
M) and PPADS (B and E, 100 M), respectively. Isc-Amil was measured
1 h after the addition of Sendai virus (106 pfu/ml). Initial Isc was
measured as the difference between the peak Isc observed following the
addition of Sendai and the Isc observed immediately prior to its
addition.
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above, the effects of Sendai virus on epithelial ion transport are
mediated by the autocrine action of ATP on apical P2Y recep-
tors. Direct activation of these receptors by exogenous nucleo-
tides should therefore reproduce the effects of the virus. We
have previously shown that apical UTP (100 M) causes a rapid
stimulation of Ca2-activated Cl secretion followed by inhibi-
tion of amiloride-sensitive Na absorption (32) (Fig. 6, compare
A with B) in the tracheal epithelium. Furthermore, the P2Y
antagonist, suramin, inhibits both the activation of Cl secre-
tion (data not shown) and the inhibition of the amiloride-
sensitive Na absorption (Fig. 6B) produced by UTP. Both
actions of UTP were also blocked by the inhibitor of phospho-
lipase C, U-73122 (32) (Fig. 6B). Finally, UTP shows a similar
divergence in the mechanisms by which it controls Cl secre-
tion and Na absorption to what we had observed with Sendai
virus; treatment of the epithelium with the protein kinase C
inhibitor BIM I inhibits the effect of UTP on Cl secretion but
leaves the inhibitory effect of UTP on the amiloride-sensitive
Na absorption unchanged (32) (Fig. 6B).
DISCUSSION
We have found that the mouse parainfluenza virus I (Sendai
virus) produces rapid changes in ion transport across mouse
tracheal epithelium. We observed these effects at concentra-
tions comparable with those observed in the nasal mucosa and
lungs of animals during experimentally induced infections,
which reach 7 
 106 pfu/g of wet weight of lung tissue and
higher within 3 days of inoculation with the virus (21, 23, 33).
In addition, the nature of the changes in ion transport ob-
served, viz. an increase in Cl secretion together with an inhi-
bition of Na absorption, suggests that they may play a signif-
icant role in the fluid accumulation in the respiratory tract that
accompanies parainfluenza infections (9, 23). Because these
effects of Sendai virus were also observed in the M1 collecting
duct cell line, it would seem that they are not mediated by
immune cells in the tracheal mucosa.
The mechanism by which Sendai produces its effects is sum-
marized in Fig. 7. It first binds to a glycolipid, which may be
asialoGM1, although our findings with the anti-sialoGM1 an-
tibody are also consistent with the weak agonist activity of this
antibody having desensitized the glycolipid target for Sendai
virus. The binding of the virus then triggers an ATP release
leading to the autocrine activation of apical P2Y receptors and
activation of phospholipase C. The pathways that activate Cl
secretion inhibit amiloride-sensitive Na absorption then di-
verge. The activation of Cl secretion is dependent on an in-
crease in intracellular Ca2 as well as on the activation of
protein kinase C, whereas the inhibition of the amiloride-sen-
sitive Na absorption is independent of increases in intracel-
lular Ca2 and the activity of protein kinase C. It is noteworthy
FIG. 4.Role of Ca2 in mediating the effects of the Sendai virus
(106 pfu/ml). A and B show the effects of incubation in low (1 M)
extracellular Ca2 solution on the initial transient increase in short
circuit current (Initial Isc) seen following the addition of the Sendai
virus and on the amiloride-sensitive short circuit current (Isc-Amil) meas-
ured 1 h after the addition of Sendai virus. C and D show the effects of
treatment with BAPTA-AM on initial Isc following the addition of
Sendai virus and on the amiloride-sensitive short circuit current
(Isc-Amil) measured 1 h after the addition of Sendai virus. Initial Isc was
measured as the difference between the peak Isc observed following the
addition of Sendai and the Isc observed immediately prior to its addi-
tion. Statistically significant effects are marked with an asterisk.
FIG. 5. Second messengers that mediate the actions of the
Sendai virus. Effects of incubation in Sendai virus (106 pfu/ml) for 1 h
on the amiloride-sensitive short circuit current (Isc-Amil) in the absence
or presence of U-0126 (A, 25 M), SB-203580 (B, 25 M), PTX (250
ng/ml) together with BIM 1 (C, 0.1 M), U-73122 (D, 10 M) and BIM (E,
0.1 M). F, summarizes the effects of these agents on the initial tran-
sient increase in short circuit current (Initial Isc) observed following
the addition of Sendai virus (106 pfu/ml). Initial Isc was measured
as the difference between the peak Isc observed following the addition of
the Sendai and the Isc observed immediately prior to its addition.
Statistically significant effects are marked with an asterisk.
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that this divergence in the regulation of these two ion transport
processes is also observed when apical P2Y receptors are di-
rectly stimulated by UTP or ATP (this work and Refs. 32
and 34).
The effects of the Sendai virus on epithelial ion transport
differ markedly from those of influenza viruses (i) Sendai virus
acts via a neuraminidase-insensitive glycolipid, whereas the
influenza receptor is neuraminidase-sensitive (16); (ii) Sendai
virus produces an initial transient stimulation of Cl secretion,
whereas influenza does not (16); and (iii) although both viruses
inhibit the amiloride-sensitive Na absorption, Sendai virus
does so via a pertussis toxin-sensitive G protein, whereas in-
fluenza does so via a pertussis toxin-insensitive G protein and
protein kinase C (16). The ability of the Sendai virus to evoke
Cl secretion is reminiscent, however, of the ability of rotavi-
ruses to trigger Cl secretion by the intestinal epithelium. This
action of rotaviruses is apparently because of a viral non-
structural protein, NSP4, activating phospholipase C, which
then increases intracellular Ca2 and triggers Cl secretion by
intestinal villus cells (35–37). It is not known whether ATP
release mediates these actions of NSP4, although the present
findings suggest that this possibility should be considered.
The present findings also need to be considered in the light of
the recent report that respiratory syncytial virus infections
inhibit the rate of fluid clearance from the airways (38). In their
studies, Davis and colleagues (38) showed that 3 days after the
infection of mice with respiratory syncytial virus there was a
marked inhibition in the rate of clearance of a standardized
volume of fluid instilled into the lungs through the trachea.
This inhibition was accompanied by a decline in the amiloride-
sensitive component of the fluid clearance and was apparently
mediated by the secretion of UTP from the respiratory mucosa.
From these studies, it was not possible to determine whether
these effects were the direct result of the contact of the virus
with the epithelium or the consequence of an immune response
to the infection. The findings in the present study, however,
suggest that they are likely to be because of a direct interaction
between the viral particles and the epithelium.
The phenomenon that most closely resembles the action of
the Sendai virus on epithelial transport is the stimulation of
epithelial cytokine and mucus production by exposure to
P. aeruginosa and Staphylococcus aureus. These bacteria trig-
ger mucus and interleukin production by binding apical asia-
loglycolipids, leading to the release of ATP, autocrine activa-
tion of purinergic receptors, and increased intracellular Ca2
(28, 29). Taking these reports together with our present finding
that the Sendai virus modulates epithelial ion transport we
propose that altered epithelial ion transport and the production
of mucus and cytokines are all part of a stereotypic response of
airway epithelia to contact with pathogens. In this response, an
increase in the volume of fluid bathing the surface of the
epithelium hydrates the increased amounts of mucus being
secreted and leads to an increase in the rate of mucus clearance
so as to facilitate transport of the pathogens out of the lung
(39). The possibility that the acute changes in electrolyte trans-
port we have observed form part of a stereotyped epithelial
response to pathogens is supported by reports that both
P. aeruginosa and Klebsiella pneumoniae inhibit Na transport
by the respiratory epithelium (40–43). A further implication of
our findings is that the release of ATP from epithelia, which
has been considered to be an epithelial response to mechanical
stimuli (44), may also play a critical role in coordinating epi-
thelial responses to pathogens.
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